Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study-Reference-Cited by-同舟云学术

Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study

Published:2011-06-20 Issue:15 Volume:17 Page:5113-5122
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

DuBois Steven G.,Shusterman Suzanne,Ingle Ashish M.,Ahern Charlotte H.,Reid Joel M.,Wu Bing,Baruchel Sylvain,Glade-Bender Julia,Ivy Percy,Grier Holcombe E.,Adamson Peter C.,Blaney Susan M.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo;European Journal of Medicinal Chemistry;2024-02

2. A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors;Pediatric Blood & Cancer;2024-01-08

3. Targeting the RET tyrosine kinase in neuroblastoma: A review and application of a novel selective drug design strategy;Biochemical Pharmacology;2023-10

4. Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805;Journal of the National Comprehensive Cancer Network;2023-07

5. Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms;Pharmaceutics;2022-12-17